Doral

Active Ingredient(s): Quazepam
FDA Approved: * December 27, 1985
Pharm Company: * MEDPOINTE PHARM HLC
Category: Sleep Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Doral Overview

Quazepam (marketed under brand names Doral, Dormalin) is a relatively long-acting benzodiazepine derivative drug developed by the Schering Corporation in the 1970s.[1] Quazepam is indicated for the treatment of insomnia including sleep induction and sleep maintenance.[2] Quazepam induces impairment of motor function and has relatively (and uniquely) selective hypnotic and anticonvulsant properties with considerably less overdose potential than other benzodiazepines (due to its novel receptor-...

Read more Doral Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Quazepam

Recent Doral Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Doral: (2 results)

Sorted by National Drug Code

• 59547-310 Doral 15 mg Oral Tablet by Nuro Pharma, Inc.
• 61825-165 Doral 15 mg Oral Tablet by Cutis Health, LLC

Other drugs which contain Quazepam or a similar ingredient: (1 result)